Quantum BioPharma Ltd. - SIC # 6371 - PENSION, HEALTH, AND WELFARE FUNDS

Ticker Exchange SIC # Website Latest Ticker
QNTM Nasdaq 6371 www.quantumbiopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Quantum BioPharma Ltd.

Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates - Jan 17th, 2025 12:30 pm
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM - Jan 14th, 2025 1:30 pm
Quantum Biopharma Ltd. Approved to Dual List on Upstream - Jan 7th, 2025 1:30 pm
Quantum Biopharma Announces Closing of Second Tranche - Dec 21st, 2024 12:30 am
Quantum Biopharma Announces Closing of First Tranche - Dec 14th, 2024 12:00 am
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - Dec 10th, 2024 12:30 pm
Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million - Dec 5th, 2024 12:30 pm
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation - Nov 25th, 2024 12:00 pm
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - Oct 29th, 2024 11:30 am
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - Oct 22nd, 2024 11:00 am
Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - Oct 21st, 2024 1:30 pm
Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - Oct 21st, 2024 11:00 am
Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America - Oct 7th, 2024 12:40 pm
Quantum Biopharma Provides Corporate Update - Sep 28th, 2024 12:06 am
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US - Sep 25th, 2024 1:20 pm
Quantum BioPharma Closes Private Placement Offering - Sep 14th, 2024 12:00 am
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - Sep 9th, 2024 11:30 am
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - Sep 6th, 2024 11:30 pm
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 - Aug 30th, 2024 2:30 pm
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT" - Aug 30th, 2024 11:30 am